SciSparc (SPRC) Times Interest Earned (2016 - 2022)

SciSparc (SPRC) posted Times Interest Earned of $0.82 for Q4 2022, up 139.89% sequentially from -$2.06 in Q3 2022.

SciSparc (SPRC) Times Interest Earned (2016 - 2022) Analysis & Trends

SciSparc has reported Times Interest Earned for 4 years, with the latest figure at $0.82 in Q4 2022.

Quarterly Times Interest Earned changed N/A year-over-year to $0.82 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $5.02 (changed N/A YoY) and the FY2025 annual result came in at -$1.02, down 112.52% from the prior year.
Times Interest Earned grew to $0.82 in Q4 2022 per SPRC's latest filing, from -$2.06 in the prior quarter.
Over five years, Times Interest Earned peaked at $1067.0 in Q1 2018 and troughed at -$260.27 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	117.59
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	8.18
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	2.82
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	76.86
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-0.08
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	1.42
10	SciSparc	831,418.60	831,418.60	-	-

Download Data